Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis

Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer therapy under development...

US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead

The U.S. Supreme Court turned away an appeal made by rebuffed efforts made by Bristol Myers Squibb Co’s (NYSE: BMY) Juno Therapeutics Inc to reinstate a $1.2 billion award it won in its patent f...